25 Sep, 2018
HyTest Supports Cancer Research
HyTest supports cancer research and families burdened with the disease
Read more
06 Sep, 2018
Summa Equity Acquires Finnish Antibody Manufacturer HyTest
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry.
Read more
30 Aug, 2018
HyTest Revenue Growth Fueled by Sales in China
During the first half of the year, HyTest’s consolidated revenue grew to 14.4 million euros.
Read more
29 Aug, 2018
Podcast: cTnI and its Proteolytic Fragments in Blood
Our latest article on cardiac troponin I was recently published in Clinical Chemistry. Now you can listen...
Read more
04 Jul, 2018
HyTest posters at Heart Failure 2018
Our researchers presented two posters at the Heart Failure Congress 2018
Read more
04 Jul, 2018
Lp-PLA2 Audioslides
Watch our presentation of this biomarker to learn more.
Read more
11 Jun, 2018
Meet us at AACC 2018 in Chicago
We will be participating the 2018 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on July 31 - August 2 in Chicago.
Read more
30 May, 2018
New HyTest Introduction Video - We are HyTest
Are you familiar with all of our different clinical areas? Or were you already aware of how many products we are able to manufacture and ship to our customers every year?
Read more
30 May, 2018
Anti-cTnT MAbs with Negligible Cross-Reactivity to Skeletal Troponin T
In high-sensitivity troponin assays, the specificity of the antibodies utilized is of utmost importance. As the clinically relevant concentration of cardiac troponin T is just nanograms per litre, even a minor cross-reactivity of the assay to skeletal troponin T isoforms could result in false positives.
Read more
26 Apr, 2018
Growth Continues - High Growth of Sales in China
During the last fiscal year HyTest’s consolidated revenue was 24.1 million euros, which equated to a year-on-year growth of 1.3%. This rate was low due to the exceptionally strong growth experienced in 2016.
Read more
24 Apr, 2018
Articles from HyTest Scientists - Receive a Free Copy!
An integral part of research is made up of the articles that are published in peer-reviewed journals. This year, three different studies conducted by our R&D team have already been published...
Read more
29 Mar, 2018
Happy Easter!
We will be closed during the Easter weekend and will be back in the office again on Tuesday.
Read more
28 Mar, 2018
New NT-proBNP MAb and Prototype Assay Developed
NT-proBNP is an established diagnostic and prognostic marker of heart failure (HF), which is a complex clinical syndrome and health problem that is associated with high morbidity and mortality rates.
Read more
28 Mar, 2018
HyTest History Animation
HyTest was established in March 1994 and since our very first day we have worked hard on a daily basis to discover the very best solutions for the needs of our customers.
Read more
23 Mar, 2018
Secure Your -10% Discount Now
Save money by ordering antibodies online. You can make your order using the discount code any time between now and 31st of May 2018.
Read more
27 Feb, 2018
Meet us at CACLP Expo and Satellite Conference
We will participate the 15th China Association of Clinical Laboratory Practice Expo held at Chongqing International Expo Center, on 17-19 March.
Read more
31 Jan, 2018
New! Human Recombinant SAA1 and SAA2
Serum amyloid A (SAA) is often used as a non-specific marker of inflammation. Its concentration in blood increases in response to inflammatory stimulus such as tissue injury, infection or trauma.
Read more
29 Jan, 2018
BNP and NT-proBNP are Established Markers of Heart Failure
Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost.
Read more
10 Jan, 2018
Come to Meet us at VMX Orlando
We will be present at the VMX: Veterinary Meeting & Expo
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!